Journal of Multiple Sclerosis and Neuroimmunology

Aims and scope

Page Path

HOME
ABOUT
Aims and scope

The Journal of Multiple Sclerosis and Neuroimmunology (JMSNI) publishes papers on disorders due to immunemediated injury of the central (CNS) and peripheral (PNS) nervous systems. The journal’s goal is to advance basic and clinical knowledge on how the nervous and immune systems interact, and how those interactions can result in diseases. JMSNI features papers that investigate many disorders that have critical neuroimmune components, such as CNS/PNS inflammatory changes, neurologic infections, neurodegeneration, and systemic autoimmune/connective tissue/inflammatory conditions. Multiple sclerosis (MS) receives special attention, because it is a critical immunemediated disorder that involves the CNS, and provides the opportunity to investigate advanced therapies in neuroimmunology.

6,005	Understanding MRI Features of Multiple Sclerosis: Based on the 2017 McDonald Criteria
2,660	Rituximab Treatment for Neuroimmunologic Disorders
2,349	National Consensus Guidance for the Diagnosis and Management of Adult Patients with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
2,323	Multiple Sclerosis in Korea: A Hospital-Based, Multicenter, Epidemiological Study
2,214	Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Review